<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study</article-title>
</title-group>
